全部股東
股東類型
- 公眾及其他49.83%
- 創投/私募31.45%
- 上市公司9.45%
- 機構投資者7.69%
- 個人與內幕人士1.58%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
Frazier Life Sciences Management, LP | 15.27% | 696.87 萬 | -- | +696.87 萬 | |
venBio LLC | 9.16% | 418.14 萬 | -- | +418.14 萬 | |
Alamar Biosciences, Inc. | 7.07% | 322.93 萬 | -- | +322.93 萬 | |
Deep Track Capital, LP | 7.03% | 320.71 萬 | -- | +320.71 萬 | |
Goldman Sachs Asset Management, L.P. | 4.31% | 196.71 萬 | -- | +196.71 萬 | |
Sanofi | 2.37% | 108.29 萬 | -- | +108.29 萬 | |
Redmile Group, LLC | 2.15% | 98.29 萬 | -- | +98.29 萬 | |
Tao FuCEO, President & Director | 1.20% | 54.86 萬 | -- | +54.86 萬 | |
The Goldman Sachs Group, Inc. | 1.03% | 46.86 萬 | -- | +46.86 萬 | |
Petter VeibyChief Scientific Officer | 0.23% | 10.50 萬 | -- | +10.50 萬 | |
Vanguard Capital Management, LLC | 0.20% | 9.06 萬 | -- | +9.06 萬 | 31/08/2026 |
Angie YouIndependent Director | 0.12% | 5.29 萬 | -- | +5.29 萬 | |
Zaneta OdrowazChief Business Officer, Treasurer & Secretary | 0.02% | 1.11 萬 | -- | +1.11 萬 | |
Hubert ChenChief Medical Officer | <0.01% | 2,960.00 | -- | +2,960.00 | |
Vanguard Portfolio Management, LLC | <0.01% | 2,430.00 | -- | +2,430.00 | 31/08/2026 |
Mitchell GoldIndependent Director | 0.00% | 0.00 | -- | +0 |